Please login to the form below

Not currently logged in
Email:
Password:

Boehringer's Wolfram Carius to step down

He will be replaced by Wolfgang Baiker on the board of managing directors

Boehringer Ingelheim Wolfram CariusBoehringer Ingelheim's Professor Wolfram Carius (pictured right) is to step down after 26 years with the German pharma company.

He will leave Boehringer on June 30 as managing director responsible for biopharmaceuticals and production, after a career that included spells in Japan and Brazil.

“We are sad to see his departure and wish him all the best on his professional and personal way ahead,” said Professor Andreas Barner, chair of Boehringer's board of managing directors.

Prof Carius will be replaced by Dr Wolfgang Baiker, who has been with Boehringer since 1989 and is currently corporate senior VP for development.

His previous roles at the company include positions in the corporate board division Research, Development and Medicine in the US and Germany.

In a statement, the company said: “The shareholders and the board of managing directors believe that with this set up in the board of managing directors, it will continue to be well-equipped for the diverse challenges that face Boehringer Ingelheim and the research-driven pharmaceutical industry worldwide.”

21st May 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics